CervoMed Inc. Common Stock

CRVONASDAQ • USD
ThemeBiotech - Drug Development›Neuroscience & CNS
2.29 USD
↗ 0.02 (0.88%)AT CLOSE (03:59 PM EDT)
2.28
↘ 0.02 (0.66%)
POST MARKET (AS OF 06:06 PM EDT)
Post Market
AS OF 06:06 PM EDT
2.28
↘ 0.02 (0.66%)
🟢Market: OPEN

CervoMed Inc. Common Stock (CRVO) is currently trading at $2.28. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Strong Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics place CRVO at a fair price relative to peers.

Technical & fundamental data as of Oct 14, 2026.

Open?$2.22
High?$2.41
Low?$2.13
Prev. Close?$2.27
Volume?493.9K
Avg. Volume?257.1K
VWAP?$2.28
Rel. Volume?1.92x
Bid / Ask
Bid?$1.94 × 100
Ask?$2.58 × 100
Spread?$0.64
Midpoint?$2.26
Valuation & Ratios
Market Cap?34.3M
Shares Out?15.1M
Float?9.5M
Float %?63.1%
P/E Ratio?N/A
P/B Ratio?1.49
EPS?-$2.01
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
Themes
Biotech - Drug Development›Neuroscience & CNSLongevity & Aging›Age-Related Therapeutics
Employees
15
Market Cap
34.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.cervomed.com
Listed
1996-06-18
Address
20 PARK PLAZA
BOSTON, MA 02116
Phone: (617) 744-4400
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookStrong Sell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
17
Short Sent.?
29
Piotroski F-Score?0/9Weak
Altman Z-Score?-2.14Distress
Confidence?62%Moderate
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?14.04%High
Short Interest?1.3M
Days to Cover?7.1
Free Float9.5M
Avg Daily Volume190.0K
Settlement Date2026-09-30
Financial Health
Current Ratio?8.57Strong
Quick Ratio?8.57Strong
Cash Ratio?7.41Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
87
1.49CHEAP▾
P/S?
Peers
100
S&P
3
103.59HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.4CHEAP▾
EV/Sales?
Peers
100
S&P
3
35.79HIGH▾
Returns & Efficiency
ROE?
S&P
3
-132.2%WEAK▾
ROA?
S&P
3
-116.8%WEAK▾
Cash Flow & Enterprise
FCF?$-27977672
Enterprise Value?$11.9M
Fundamentals ratios updated end of day
MarketsMoversWatchlist